Physician profile
Denise Leonard
NPI 1457349581
$1,938.81
in general payments reported to CMS, 2019-2025
25 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2021: $88.67 · 2022: $235 · 2023: $400 · 2024: $599 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.10 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $600.00 | 2024-2025 | Bovine Collagen |
| Hologic Sales and Service, LLC | $173.37 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Pacira Pharmaceuticals Incorporated | $164.89 | 2023 | Exparel |
| Astellas Pharma US INC | $120.31 | 2023-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $101.32 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $91.28 | 2022-2025 | |
| Shield Therapeutics INC | $82.82 | 2023 | Accrufer |
| Pfizer INC. | $76.44 | 2022-2024 | |
| Evofem Biosciences, INC. | $60.87 | 2021-2022 | |
| Agile Therapeutics, INC. | $55.39 | 2022-2024 | Twirla |
| Mission Pharmacal Company | $51.76 | 2019-2023 | Citranatal |
| Roche Diagnostics Corporation | $46.90 | 2019 | |
| Biogen, INC. | $46.73 | 2024-2025 | Zurzuvae |
| Organon LLC | $35.70 | 2022 | |
| Sumitomo Pharma America, INC. | $28.69 | 2023 | Myfembree |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.67 | 2019 | |
| Exeltis, USA INC. | $25.82 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $24.63 | 2019 | |
| Avanos Medical | $23.00 | 2019 | |
| Mylan Pharmaceuticals INC. | $22.43 | 2022 | |
| Abbvie INC. | $20.02 | 2021 | |
| Merck Sharp & Dohme LLC | $17.98 | 2019 | |
| Ethicon US, LLC | $15.77 | 2019 | |
| Lsi Solutions INC | $14.34 | 2019 | |
| Minerva Surgical, INC | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.